(19)
(11) EP 0 765 390 A1

(12)

(43) Date of publication:
02.04.1997 Bulletin 1997/14

(21) Application number: 95924467.0

(22) Date of filing: 12.07.1995
(51) International Patent Classification (IPC): 
A01K 67/ 027( . )
A23C 9/ 20( . )
C12N 5/ 10( . )
C12N 15/ 85( . )
A23C 9/ 00( . )
C07K 14/ 76( . )
C12N 15/ 09( . )
C12P 21/ 02( . )
(86) International application number:
PCT/GB1995/001651
(87) International publication number:
WO 1996/002640 (01.02.1996 Gazette 1996/06)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 13.07.1994 WO 1994GB01514
15.12.1994 GB 19940025326
31.01.1995 US 19950381691
25.02.1995 GB 19950003822

(71) Applicant: PPL Therapeutics (Scotland) Limited
Edinburgh, Midlothian EH25 9PP (GB)

(72) Inventors:
  • COOPER, Julian
    Blacksburn, VA 24060 (US)
  • SCHNIEKE, Angelike
    Edinburgh EH10 5PD (GB)

(74) Representative: Pattullo, Norman, et al 
Murgitroyd and Company 373 Scotland Street
Glasgow G5 8QA
Glasgow G5 8QA (GB)

   


(54) ALPHA-LACTALBUMIN GENE CONSTRUCTS